fluorouracil

Type: Product

Name: fluorouracil

First reported 6 hours ago - Updated 6 hours ago - 1 reports

Gordon Lehman

A UV radiation induced thymine-thymine cyclobutane dimer (right) is the type of DNA damage which is undone by photolyase. (Photo credit: Wikipedia)Having thus far avoided grossing everyone out with pictures of my penance for past overindulgence in photons, ... [Published North Bay Business Journal - 6 hours ago]

Entities: Photon, fluorouracil, Thymine

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Report: Market for Pancreatic Cancer Therapies Expected to Double to $1.3 Billion Over Next Decade

Growth fueled by three new agents (May 7)Decision Resources, a research and advisory firm located in Burlington, Mass., finds that the pancreatic cancer therapy market will nearly double to $1.3 billion in 2022, owing to the launch and rapid uptake of ... [Published PT Community - May 08 2013]

Entities: Pancreatic Cancer, Abraxane, Leucovorin Calcium, Patient, Onconova Therapeutics Inc

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases

Purpose To assess the effects of cetuximab plus chemotherapy as first-line treatment for unresectable colorectal liver metastases (CLMs).Patients and Methods After resection of their primary tumors, patients with KRAS wild-type synchronous nonresectable ... [Published Journal of Clinical Oncology - May 06 2013]

Entities: cetuximab, Patient, Chemotherapy, Metastases

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Upper Egypt experience in bladder preservation using concurrent chemoradiotherapy

ObjectiveTo share our experience in bladder preservation in Upper Egypt, Assiut and Sohag Universities, using different treatment protocols. In Sohag study patients with operable muscle invasive bladder cancer were included and underwent transurethral ... [Published 7thSpace - May 06 2013]

Entities: chemoradiotherapy, Patient, Tumor, Sohag (Egypt)

First reported May 04 2013 - Updated May 04 2013 - 1 reports

NCCN's First Guidelines for Penile Cancer Say Preservation Therapy is Feasible

HOLLYWOOD, Fla.—New treatment guidelines for penile cancer from the National Comprehensive Cancer Network (NCCN) suggest that conservative treatment should be considered for this rare cancer, according to the report released here at the organization's ... [Published Oncology Times - May 04 2013]

Entities: Tumor, Cancer, Patient, guidelines

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Oncology Drug Shortages Affecting Care for Cancer Patients

Survey Finds Shortages Leading to Treatment Delays, Missed DosesA new study of the effects of oncology drug shortages, published in the April 1 edition of the American Journal of Health-System Pharmacy (AJHP), reveals that cancer patients are paying a ... [Published Oncology Business Review - Apr 30 2013]

Entities: Oncology, Drugs, Cancer

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

[Comment] ACT II: treatment of anal cancer comes full circle

In 1974, Nigro and colleagues reported the results of treatment of three patients with anal cancer with preoperative pelvic radiation therapy (30 Gy in 15 fractions) with one cycle of fluorouracil (25 mg/kg per 24 h) infused continuously over 5 days and ... [Published Lancet Oncology - Apr 30 2013]

Entities: Anal Cancer, Infusion, mitomycin, fluorouracil, bolus

First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Pancreatic Adenocarcinomas – Update on diagnostic tools and treatment modalities

Pancreatic Adenocarcinomas - Update on diagnostic tools and treatment modalitiesWorldwide, pancreatic cancer is the 13th most common adult malignancy but eighth in terms of cancer death.1 In Singapore, the incidence of pancreatic cancer has increased ... [Published Medical Grapevine - Apr 22 2013]

Entities: Pancreatic Cancer, gemcitabine, adenocarcinoma, Tumor, chemoradiotherapy

First reported Apr 18 2013 - Updated Apr 18 2013 - 1 reports

Metastatic Colorectal Cancer: FOLFOXIRI Remains Superior to FOLFIRI

SAN FRANCISCO—Previous Phase III trials have shown that FOLFOXIRI is superior to FOLFIRI in first-line metastatic colorectal cancer, and Phase II data have suggested that also remains true when bevacizumab is added to each arm. Now, Phase III results ... [Published Oncology Times - Apr 18 2013]

Entities: FOLFIRI, bevacizumab, Metastatic Colorectal Cancer

First reported Apr 09 2013 - Updated Apr 09 2013 - 1 reports

Comment ACT II treatment of anal cancer comes full circle

Home » Articles » [Comment] ACT II: treatment of anal cancer comes full circleIn 1974, Nigro and colleagues reported the results of treatment of three patients with anal cancer with preoperative pelvic radiation therapy (30 Gy in 15 fractions) with one ... [Published BioPortfolio - Apr 09 2013]

Entities: Anal Cancer, Biotechnology, Health Care, fluorouracil

First reported Feb 21 2013 - Updated Feb 21 2013 - 1 reports

EFUDEX (Fluorouracil) Solution EFUDEX (Fluorouracil) Cream [Valeant Pharmaceuticals International]

Updated Date: Feb 21, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 21 2013]

Entities: fluorouracil, Valeant Pharmaceuticals International

Quotes

...the state of North Carolina refused to renew a wholesaler license for a company called International Pharmaceuticals in 2011 because the company "willfully violated NC wholesale prescription drug distribution laws for an extended period of time during 2011." In 2012, however, the company still had active wholesaler licenses in at least 23 other states

Cummings Introduces Bill to Reform 'Gray Market' Drug Sales [Published Pharmacy Choice - May 18 2013]

Prof. Dr. Ahmad Awada, Initiator of the IIT and Head of the Medical Oncology Clinic at the Institut Jules Bordet in Brussels, Belgium, commented: "The study results support the promising anti-tumoural effect of EndoTAG®-1 in combination with weekly Paclitaxel which were observed in previous phase II conducted studies. The marked reduction in tumour volume observed in TNBC patients during this IIT suggests a further clinical development in this indication with high unmet medical need."

Medigene AG: Medigene publishes final results from phase II Investigator Initiated Trial of EndoT ... [Published FinanzNachrichten.de - May 15 2013]

"FIG. 4 shows combination index (CI) values for the inhibition of COX-2 enzyme activity by ethyl acetate (upper panel) and methylene chloride (lower panel) extracts of the individual botanicals Ganoderma lucidum (#9), Scutellaria barbata (#15), and Salvia miltiorrhiza (#14) and combinations thereof."

"Compositions of Botanical Extracts for Cancer Therapy" in Patent Application Approval Process [Published Pharmacy Choice - May 09 2013]

More Content

sort by: Date \| Relevance
Gordon Lehman [Published North Bay Business Journal - 6 hours ago]
Cummings Introduces Bill to Reform 'Gray Market... [Published Pharmacy Choice - May 18 2013]
Adding Cetuximab Promising in Making Colorectal... [Published Oncology Times - May 18 2013]
Breast Cancer Drug, EndoTAG-1, Shows Promise in... [Published P&T Community - May 17 2013]
Medigene AG: Medigene publishes final results f... [Published FinanzNachrichten.de - May 15 2013]
Medigene publishes final results from phase II ... [Published Best Invest - May 15 2013]
Survey: Drug Shortages May Weaken Cancer Care [Published Pharmacy Practice News - May 14 2013]
There’s no home remedy for relief from COPD [Published New Jersey Herald - May 12 2013]
Dear Dr. Roach: Steroids, oxygen can help those... [Published Herald & Review - May 11 2013]
Keith Roach: There's no home remedy for COPD [Published Detroit News - May 10 2013]
"Compositions of Botanical Extracts for Cancer ... [Published Pharmacy Choice - May 09 2013]
Report: Market for Pancreatic Cancer Therapies ... [Published PT Community - May 08 2013]
Randomized Controlled Trial of Cetuximab Plus C... [Published Journal of Clinical Oncology - May 06 2013]
Upper Egypt experience in bladder preservation ... [Published 7thSpace - May 06 2013]
NCCN's First Guidelines for Penile Cancer Say P... [Published Oncology Times - May 04 2013]
Researchers Submit Patent Application, "Low Tox... [Published Equities.com - May 01 2013]
Oncology Drug Shortages Affecting Care for Canc... [Published Oncology Business Review - Apr 30 2013]
[Comment] ACT II: treatment of anal cancer come... [Published Lancet Oncology - Apr 30 2013]
New Market Report Now Available: Bile Duct Canc... [Published Live-PR.com - Apr 25 2013]
Sirtex's Tiny Beads Could See Great Success In ... [Published Seeking Alpha - Apr 22 2013]
Pancreatic Adenocarcinomas – Update on diagnost... [Published Medical Grapevine - Apr 22 2013]
Metastatic Colorectal Cancer: FOLFOXIRI Remains... [Published Oncology Times - Apr 18 2013]
Comment ACT II treatment of anal cancer comes f... [Published BioPortfolio - Apr 09 2013]
Solid dosage form that promotes reliable oral, ... [Published PharmCast - Mar 14 2013]
EFUDEX (Fluorouracil) Solution EFUDEX (Fluorour... [Published DailyMed Drug Label Updates for the last seven ... - Feb 21 2013]
‘It’s such a high-risk medication’: Researchers... [Published National Post - Top Stories - Feb 04 2013]
Solid drug tablets for implantable drug deliver... [Published PharmCast - Jan 15 2013]
Molecular signature of cancer [Published PharmCast - Jan 13 2013]
Topical compositions and methods for epithelial... [Published PharmCast - Jan 02 2013]
Adherex Reports Positive Preliminary Interim Ph... [Published Marketwire - Breaking News Releases - Dec 10 2012]